Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.
Open Access
- 15 April 1998
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 101 (8) , 1775-1783
- https://doi.org/10.1172/jci1940
Abstract
An arginine to glutamine missense mutation at position 403 of the beta-cardiac myosin heavy chain causes familial hypertrophic cardiomyopathy. Here we study mice which have this same missense mutation (alphaMHC403/+) using an isolated, isovolumic heart preparation where cardiac performance is measured simultaneously with cardiac energetics using 31P nuclear magnetic resonance spectroscopy. We observed three major alterations in the physiology and bioenergetics of the alphaMHC403/+ mouse hearts. First, while there was no evidence of systolic dysfunction, diastolic function was impaired during inotropic stimulation. Diastolic dysfunction was manifest as both a decreased rate of left ventricular relaxation and an increase in end-diastolic pressure. Second, under baseline conditions alphaMHC403/+ hearts had lower phosphocreatine and increased inorganic phosphate contents resulting in a decrease in the calculated value for the free energy released from ATP hydrolysis. Third, hearts from alphaMHC403/+ hearts that were studied unpaced responded to increased perfusate calcium by decreasing heart rate approximately twice as much as wild types. We conclude that hearts from alphaMHC403/+ mice demonstrate work load-dependent diastolic dysfunction resembling the human form of familial hypertrophic cardiomyopathy. Changes in high-energy phosphate content suggest that an energy-requiring process may contribute to the observed diastolic dysfunction.Keywords
This publication has 16 references indexed in Scilit:
- Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice.Journal of Clinical Investigation, 1997
- Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart.Journal of Clinical Investigation, 1997
- A Mouse Model of Familial Hypertrophic CardiomyopathyScience, 1996
- Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.Journal of Clinical Investigation, 1995
- Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.Circulation, 1994
- Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cellsNature, 1991
- Noninvasive assessment of left ventricular diastolic function by pulsed doppler echocardiography in patients with hypertrophic cardiomyopathyJournal of the American College of Cardiology, 1987
- The cytoplasmic phosphorylation potential: Its possible role in the control of myocardial respiration and cardiac contractilityJournal of Molecular and Cellular Cardiology, 1985
- Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients.Circulation, 1982
- Microassay of free and total creatine from tissue extracts by combination of chromatographic and fluorometric methodsAnalytical Biochemistry, 1973